Metronidazole SR Pellets Manufacturer in India

Metronidazole SR Pellets – Pharmaceutical-Grade Sustained-Release Pellets

Metronidazole SR Pellets are pharmaceutical-grade multiparticulate pellets containing Metronidazole and designed for sustained-release oral dosage-form development. The pellet format provides a flexible platform for capsule filling and other multiparticulate pharmaceutical formulations.

Metronidazole has CAS Number 443-48-1, molecular formula C₆H₉N₃O₃, and molecular weight 171.15 g/mol. The USP-NF monograph defines Metronidazole at 99.0%–101.0%, calculated on the dried basis.

Commercial pharmaceutical-pellet listings specifically include Metronidazole SR Pellets, with one Indian manufacturer listing a 60% presentation. This is a commercial reference and should not be treated as the SDP finished-pellet strength unless confirmed by the applicable SDP specification.

Key Features

• Metronidazole SR Pellets
• Pharmaceutical Grade
• Sustained-release multiparticulate pellet format
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Product-specific active-ingredient loading
• Controlled-release formulation platform
• Free-flowing multiparticulate format
• Product-specific particle-size and dissolution characteristics
• Suitable for bulk pharmaceutical formulation requirements

Metronidazole Sustained-Release Pellets

Metronidazole Sustained-Release Pellets are designed around a multiparticulate formulation approach in which the release profile can be controlled through the pellet composition and, where applicable, a functional coating or release-controlling matrix.

The final release characteristics depend on factors such as active-ingredient loading, pellet size, excipient system, polymer/coating characteristics, coating weight gain and manufacturing conditions.

For this reason, the finished Metronidazole SR Pellets specification should be established independently from the Metronidazole API specification.

Applications

Metronidazole SR Pellets can be considered for:

• Sustained-release capsule formulations
• Multiparticulate oral formulations
• Capsule filling
• Controlled-release formulation development
• Pellet-based oral dosage-form development
• Pharmaceutical formulation research
• Combination multiparticulate formulations where technically compatible
• Bulk pharmaceutical manufacturing requirements

Manufacturing & Processing

Metronidazole SR Pellets may be manufactured using suitable pelletization, layering and functional-coating technologies.

Important product parameters may include:

• Active-ingredient loading
• Pellet-size distribution
• Assay
• Moisture content
• Content uniformity
• Pellet morphology
• Mechanical strength
• Friability
• Coating weight gain
• Dissolution profile
• Sustained-release performance

These characteristics should be controlled according to the approved finished-product specification.

Quality & Testing

Metronidazole SR Pellets may be evaluated for:

• Identification by HPLC / suitable analytical technique
• Assay by HPLC
• Related substances
• Loss on drying
• Water content
• Residue on ignition where applicable
• Particle-size distribution
• Pellet morphology
• Mechanical strength / friability
• Content uniformity
• Dissolution testing
• Sustained-release profile
• Coating uniformity where applicable

The USP-NF Metronidazole monograph specifies 99.0%–101.0% assay on the dried basis for the API. This is an API specification and should not automatically be used as the finished-pellet assay range.

Why Metronidazole SR Pellets from Swapnroop?

Metronidazole SR Pellets from Swapnroop are positioned as pharmaceutical-grade multiparticulate pellets for sustained-release formulation development and capsule-filling applications.

• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Sustained-Release Format – Developed for formulations requiring a controlled release profile.
• Product-Specific Active Loading – Loading can be defined according to the applicable product specification.
• Multiparticulate Formulation – Suitable for capsule filling and other oral dosage-form development.
• Controlled Quality Parameters – Assay, moisture, particle size and dissolution can be evaluated according to the applicable specification.
• Formulation Flexibility – Pellet characteristics can be established according to the intended formulation requirements.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical formulation and manufacturing requirements.
• Quality-Focused Processing – Product parameters can be controlled according to the approved specification.

Packaging & Bulk Supply

Metronidazole SR Pellets can be supplied in suitable pharmaceutical bulk packaging according to the applicable product specification. Active loading, pellet size, release characteristics, packaging configuration and analytical requirements should be confirmed before commercial supply.

Get Bulk Quote via WhatsApp